National Asset Management, Inc. Fortress Biotech, Inc. Transaction History

National Asset Management, Inc.

$4.29 Billion
Q1 2024

A detailed history of National Asset Management, Inc. transactions in Fortress Biotech, Inc. stock. As of the latest transaction made, National Asset Management, Inc. holds 144,700 shares of FBIO stock, worth $247,437. This represents 0.01% of its overall portfolio holdings.

Number of Shares

144,700

Holding current value

$247,437

% of portfolio

0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 16, 2024	BUY	$1.68 - $2.69 $243,096 - $389,243	144,700 New	144,700 $289,000
Q3 2023 Dec 01, 2023	SELL	$0.28 - $0.65 $8,428 - $19,565	-30,100 Reduced 17.22%	144,700 $41,000
Q2 2023 Jul 27, 2023	SELL	$0.49 - $0.82 $3,332 - $5,576	-6,800 Reduced 3.74%	174,800 $96,000
Q1 2023 May 17, 2023	BUY	$0.65 - $1.1 $10,920 - $18,480	16,800 Added 10.19%	181,600 $148,000
Q3 2022 Nov 14, 2022	BUY	$0.79 - $22.0 $4,740 - $132,000	6,000 Added 3.78%	164,800 $142,000

Q2 2022 Aug 12, 2022	BUY	$0.8 - $1.5 $10,600 - $19,875	13,250 Added 9.1%	158,800 $134,000
Q1 2022 May 02, 2022	BUY	$1.24 - $2.75 $42,160 - $93,500	34,000 Added 30.48%	145,550 $198,000
Q4 2021 Jan 28, 2022	BUY	$2.42 - $3.65 $140,844 - $212,430	58,200 Added 109.09%	111,550 $279,000
Q3 2021 Nov 16, 2021	BUY	$2.82 - $3.7 $26,338 - $34,558	9,340 Added 21.22%	53,350 $172,000
Q2 2021 Aug 10, 2021	SELL	$3.5 - $5.48 $57,750 - $90,420	-16,500 Reduced 27.27%	44,010 $157,000
Q1 2021 May 13, 2021	BUY	$3.16 - $4.89 $15,800 - $24,450	5,000 Added 9.01%	60,510 $214,000
Q4 2020 Feb 04, 2021	SELL	$2.2 - $4.45 $35,829 - $72,472	-16,286 Reduced 22.68%	55,510 $176,000
Q3 2020 Nov 09, 2020	BUY	$2.62 - $4.78 $37,479 - $68,377	14,305 Added 24.88%	71,796 $285,000
Q2 2020 Jul 31, 2020	SELL	$1.83 - $3.16 $46,665 - $80,580	-25,500 Reduced 30.73%	57,491 $154,000
Q1 2020 May 06, 2020	BUY	$1.14 - $2.96 $17,364 - $45,086	15,232 Added 22.48%	82,991 $157,000
Q4 2019 Feb 10, 2020	BUY	$1.25 - $2.57 $11,510 - $23,664	9,208 Added 15.73%	67,759 $167,000
Q3 2019 Nov 12, 2019	BUY	$1.26 - $1.96 $4,084 - $6,354	3,242 Added 5.86%	58,551 $83,000
Q2 2019 Aug 05, 2019	SELL	$1.43 - $1.94 $1,584 - $2,149	-1,108 Reduced 1.96%	55,309 $85,000
Q1 2019 May 08, 2019	BUY	$0.94 - $2.47 $8,225 - $21,612	8,750 Added 18.36%	56,417 $88,000
Q4 2018 Feb 08, 2019	BUY	$0.57 - $1.53 $2,602 - $6,984	4,565 Added 10.59%	47,667 $41,000
Q3 2018 Nov 08, 2018	BUY	$1.44 - $3.13 $8,079 - $17,562	5,611 Added 14.97%	43,102 $69,000
Q2 2018 Oct 05, 2018	SELL	$2.92 - $5.1 $379 - $663	-130 Reduced 0.35%	37,491 $112,000
Q1 2018 May 15, 2018	BUY	$3.42 - $5.35 $22,424 - $35,079	6,557 Added 21.11%	37,621 $171,000
Q4 2017 Feb 15, 2018	BUY	$3.26 - $4.84 $9,555 - $14,186	2,931 Added 10.42%	31,064 $124,000
Q3 2017 Nov 13, 2017	SELL	$3.83 - $4.89 $2,746 - $3,506	-717 Reduced 2.49%	28,133 $125,000
Q2 2017 Aug 15, 2017	BUY	N/A	28,850	28,850 $138,000

Others Institutions Holding FBIO

# of Institutions

Shares Held

1.01M

Call Options Held

Put Options Held

View Full List

About Fortress Biotech, Inc.

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $184M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

More about FBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.

Account

National Asset Management, Inc. Fortress Biotech, Inc. Transaction History